Virtual collaborative care program for type 2 diabetes and mental health
Official title: Bridging Gaps, Enhancing Wellbeing: Examining the Effectiveness of the Technology-Enabled Collaborative Care for Diabetes and Mental Health (TECC-DM) Model
Run by McMaster University · NCT07181863 · Data updated 2026-11-12
This program will test whether virtual health coaching with support from an interdisciplinary care team helps adults with type 2 diabetes and anxiety, depression, or diabetes distress manage their health better than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | McMaster University Academic / other |
| Locations | 2 sites (Hamilton, Ontario and 1 other locations) |
| Status | Recruiting |
| Started | March 16, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07181863 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults age 18 or older who live in Ontario, have diagnosed type 2 diabetes, and meet thresholds for anxiety/depression (HADS ≥8) or diabetes distress (DDS ≥2), and can communicate in English are ideal candidates.
✕Probably not a fit
People with severe mental illness (for example schizophrenia or psychotic disorders), those living outside Ontario, non-English speakers, or those without access to virtual services may not be eligible or receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial randomizes about 160 adults with type 2 diabetes and co-occurring mental health symptoms to receive either the TECC-DM intervention or usual care. TECC-DM combines weekly virtual health coaching calls, educational emails, online self-management tools, and support from an interdisciplinary care team, delivered in addition to existing diabetes care. The study measures patient-relevant outcomes such as quality of life and diabetes distress, as well as provider satisfaction, and includes parallel implementation research using input from a partner advisory group. Participants are enrolled and followed by a team led at McMaster University with collaborators including CAMH and Diabetes Canada.
Why it matters
Potential benefit: If successful, the program could help people with type 2 diabetes and mental health symptoms improve self-management and quality of life through coordinated virtual support.
How similar studies have gone: Collaborative care and virtual coaching models have shown promise in prior studies and the TECC-DM team reports feasibility data, but the full effectiveness of this integrated virtual model is still being tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ≥18 years old * Diagnosed with type 2 diabetes (T2D) * Experiencing mental health challenges, defined as: * Hospital Anxiety and Depression Scale (HADS) score ≥8 on either subscale OR * Diabetes Distress Scale (DDS) score ≥2 * Community-living * Able to communicate verbally in English * Residing in Ontario during study participation Exclusion Criteria: * Diagnosis of severe mental illness (e.g., schizophrenia, psychotic disorder)
Where it's running
-
University of Toronto
Toronto, Ontario, Canada Recruiting -
McMaster University
Hamilton, Ontario, Canada Active not recruiting
Study contacts
- Principal investigator: Carly Whitmore, RN PhD — University of Toronto
- Study coordinator: Lucy Kervin, PhD
- Email: lucy.kervin@utoronto.ca
- Phone: 416 946 3434
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Healing Hearts: A Mindfulness App for Parents Navigating Divorce or Separation
A online program tests a self-guided mindfulness app for distressed parents going through divorce or separation, to see if it helps parent and child wellbeing.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.